At least 50 medication mix-ups recently prompted the Food and Drug Administration to issue a warning to the public. Specifically, the warning pertains to two drugs with very similar-sounding names: Brintellix and Brilinta.
Brintellix is used to treat depression, and Brilinta is an anti-clotting medication. The FDA says that doctors and pharmacists have been getting the names confused, potentially causing harm to patients, though no injuries have yet been reported. More than 1.5 million prescriptions for Brintellix and Brilinta have been written, so the FDA's warning is relevant for many Americans.